Home/ Stocks/ ALBT

Avalon GloboCare Corp. Common Stock

ALBT XNAS

$0.58 -0.06 (-9.40%) ▼ 15-min delayed

Open

$0.65

High

$0.66

Low

$0.55

Volume

155.3K

Market Cap

$4.19M

About Avalon GloboCare Corp. Common Stock

Avalon Globocare Corp is an intelligent biotech developer and healthcare service provider dedicated to promoting and empowering high-impact, transformative biotechnology, clinical applications, and healthcare facility management. The company has two reportable segments: the real property operating segment, which is the key revenue driver, and the laboratory testing services segment. The company focuses on diagnostic and therapeutic areas like early detection of oral cancer, ovarian cancer, kidney cancer, skin regeneration and anti-fibrosis, and treatments of degenerative disorders.

Sector: SERVICES-COMPUTER PROGRAMMING SERVICES Employees: 5 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	$350.1K	$-254,268	$-0.06
Q2 2025	$350.4K	$-13,458,598	$-6.22
Q1 2025	$349.8K	$-2,482,111	$-1.43
FY 2024	$1.33M	$-7,903,394	$-8.44

TickerDaily Coverage

Why Is Avalon GloboCare Corp. Common Stock (ALBT) Stock Up 132.2% Today?

Penny Stocks Marcus Rivera · Feb 27, 2026

Avalon GloboCare Corp. (ALBT) stock exploded 132.2% to $1.09 on a private placement announcement...

Why Is Avalon GloboCare Corp. Common Stock (ALBT) Stock Up 140.1% Today?

Penny Stocks Marcus Rivera · Feb 26, 2026

Avalon GloboCare Corp. (ALBT) stock ripped 140.1% higher to $0.5082 after announcing an all-stock...

View All Coverage →

Get ALBT Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Avalon GloboCare Corp. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.